Issue 40, 2022, Issue in Progress
From the journal:

RSC Advances

Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii

Sajal Kumar Halder,ab   Maria Mulla Mim,c   Md. Meharab Hassan Alif,a   Jannatul Fardous Shathi,a   Md. Nuhu Alam,d   Aparna Shil*d  and  Mahbubul Kabir Himel*d  

* Corresponding authors

a Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh

b Research Assistant at Padma Bioresearch, Dhaka, Bangladesh

c Department of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh

d Department of Botany, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh
E-mail: himelbotju@juniv.edu, aparna@juniv.edu

Abstract

Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2RA90089K
Article type
Correction
Submitted
31 Aug 2022
Accepted
31 Aug 2022
First published
12 Sep 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 25923-25923

Permissions

Request permissions

Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii

S. K. Halder, M. M. Mim, Md. M. H. Alif, J. F. Shathi, Md. N. Alam, A. Shil and M. K. Himel, RSC Adv., 2022, 12, 25923 DOI: 10.1039/D2RA90089K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements